tumor markers: a proteomic approach

نویسندگان

afshin abrishamkar institute of chemical and bioengineering, department of chemistry and applied bioscience, swiss federal institute of technology zurich (ethz), zurich, switzerland

saeed heidari keshel proteomics research center, shahid beheshti university of medical sciences, tehran, iran

eiman rahnema falavarjani sharif university of technology, chemical and petroleum engineering department, tehran, iran

maryam ebrahimi proteomics research center, shahid beheshti university of medical sciences, tehran, iran

چکیده

this article reviews the recently published data on the diagnosis of cancer with proteomics, including the major proteomics technologies and promising strategies for biomarker discovery and development.  most of the tumor markers are proteins that either numerically increase in response to the alteration of cancer conditions or are produced by cancer cells. however, they are natural compounds ordinarily available in the typical cells to a little extent what are affected by increase of expression due to cancer and its intensity in blood, body fluids or tissues. tumor markers are substances normally available in body fluids such as serum, urine, blood, and tissues that increase in the desired tissue of cancer patients. most of tumor markers are proteins that either are produced in response to changes in cancer conditions or are made by the cancer cells. however, most of tumor markers are among the natural compounds of normal cells present in normal conditions in the cell in small amounts and are affected by increase of expression, due to cancer and their levels in the blood, body fluids or tissues.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A Proteomic Approach to the Identification of Lung Cancer Markers

We have developed a comprehensive approach to the identification of protein markers in lung cancer that includes profiling of tumor tissue and cell lines as well as the analysis of serum for autoantibodies to lung tumor antigens. A large number of proteins that are differentially expressed in the major subtypes of lung cancer have been identified by mass spectrometry. A database of protein expr...

متن کامل

Proteomic-Based Approach for the Identification of Tumor Markers Associated with Hepatocellular Carcinoma

There is increasing evidence for an immune response to cancer in humans, demonstrated in part by the identification of autoantibodies to tumor antigens. The identification of panels of tumor antigens that elicit a humoral response may have utility in cancer screening, diagnosis or in establishing prognosis. Several approaches are currently available for the identification of tumor antigens. We ...

متن کامل

Identification of Agents with Potential Leishmania Malate Dehydrogenase Inhibitor Activity: A Proteomic and Molecular Docking Approach

 Background and purpose: Leishmaniasis is one of the most important infectious diseases caused by different species of the Leishmania, which is a public health problem worldwide. So far, no effective vaccine is introduced for this disease and drug therapy is associated with many side effects. Therefore, this study was designed to identify novel FDA-approved compounds with anti-leishmanial activ...

متن کامل

A proteomic approach for the identification of vascular markers of liver metastasis.

Vascular proteins expressed at liver metastasis sites could serve as prognostic markers or as targets for pharmacodelivery applications. We employed a proteomic approach to define such proteins in three syngeneic mouse models of liver metastasis. Vascular structures were biotinylated in vivo by a terminal perfusion technique, followed by mass spectrometric analysis of accessible biotinylated pr...

متن کامل

A Proteomic Approach for the Discovery of Early Detection Markers of Hepatocellular Carcinoma

Individuals chronically infected with hepatitis B or C virus (HBV, HCV) are at high risk for the development of hepatocellular carcinoma (HCC), with disease progression occurring relentlessly over many years. The diagnosis of HCC usually occurs at late stages in the disease when there are few effective treatment options and the prognosis for patients with HCC is very poor. The long latency peri...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
journal of paramedical sciences

جلد ۵، شماره ۱، صفحات ۰-۰

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023